University of Hawaii braces for potential job losses, funding cuts
UH President Wendy Hensel addressed these concerns during an open forum held today, where she discussed how the new federal directives could impact the university system's 10 campuses across the state.
Lawmakers drill UH President and Board on budget requests
The university operates on a budget of $1.3 billion, with $636 million coming from the state, $410 million from tuition, and $370 million from federal funding.
However, Hensel warned that with the new federal policies in place, as many as 2,500 jobs could be at risk. This represents a significant portion of the university's 16,000 employees.
In addition to potential job cuts, critical programs could be affected, including technical training at community colleges, initiatives serving Native Hawaiians, and biomedical research efforts.
Hensel emphasized that biomedical research, which often leads the way in drug development, vaccine creation, and disease prevention, is especially at risk.'We don't want to quantify what's going to happen with biomedical research, but clearly it's at risk,' Hensel said.
'Nobody predicted, that I know of, that we would be having this kind of conversation. This is the kind of research that's usually at the top of the list. But if the NIH cap going forward persists, it will have serious implications for our biomedical research.'
Biomedical research at UH includes critical work in testing new drugs, developing vaccines, and finding ways to prevent or cure diseases—efforts that could be severely hindered by the loss of federal funding.
Check out more news from around Hawaii
To provide ongoing updates and support during this uncertain time, UH has launched a 'Federal Policy Update Resource Page' to keep students, faculty, and staff informed about developments and to offer guidance on how to navigate the changes.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
Faced with choosing, NYC Mayor Adams nods toward running on ‘Safe and Affordable' ballot line
Mayor Adams appears to be leaning toward selecting 'Safe&Affordable' as his ballot line in November's election as opposed to 'EndAntiSemitism' after New York City's elections board told him late Tuesday he must soon pick one of them. Still, Adams — who has made support for Israel and fighting antisemitism key focuses of his reelection bid — vowed Wednesday to mount a legal challenge to be able to run on both lines. It's unclear if there's enough though time for him to mount such a court case. In a letter sent to Adams late Tuesday, a copy of which was obtained by the Daily News, the BOE wrote he needs to 'inform this Board in writing within five business days of the date of this letter of your choice as to which row or column you wish to have.' If Adams doesn't make a pick by that deadline, Vincent Ignizio, the board's deputy executive director, told The News the panel 'will select for him.' In response, Adams campaign spokesman Todd Shapiro said in a statement Wednesday the mayor 'intends to pursue legal options' to still try and appear on both lines. While he didn't say it outright, Shapiro's statement also suggested 'Safe&Affordable' is Adams' likely selection if it turns out he has to select one. 'At the same time, voters can be confident that Mayor Adams will appear on the Safe and Affordable ballot line in all five boroughs — ensuring millions of New Yorkers will have their voices heard at the polls,' the statement said. The Board of Elections has for months told Adams to select a single ballot line, maintaining that state law holds independent candidates can only run on one. In response, Adams has for months said he would challenge that determination in court. He has yet to file any court case, though. Adams, who's facing an uphill climb in the mayoral election running as an independent candidate, collected enough petition signatures to qualify for both lines. Still reeling from political fallout over his federal corruption indictment, Adams' reelection effort is seen as a long shot. He's polling far behind Democratic mayoral nominee Zohran Mamdani, the favorite to win November's election. Solve the daily Crossword
Yahoo
16 hours ago
- Yahoo
Veradigm Amends and Extends Stockholder Rights Plan
CHICAGO, August 20, 2025--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires beneficial ownership of 20% or more of the outstanding shares of Company common stock (including in the form of synthetic ownership through derivative positions) in a transaction not approved by the Board, whether or not such person or group is an eligible passive investor. The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Rights Plan continue to be present. Accordingly, the Rights Plan is being extended to continue to ensure that all Veradigm stockholders have the opportunity to realize the full potential value of their investment. The Rights Plan does not prevent the Company from pursuing any offer that is fair and otherwise in the best interests of stockholders. The Board currently intends to terminate the Rights Plan no later than the time that the Company becomes current in its financial reporting and has applied for relisting of its shares of common stock on a national stock exchange, which is expected to occur in 2026. Further details about the Rights Plan, as amended, will be contained in a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission. About Veradigm® Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube. © 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved. Disclaimer and Forward-Looking Statement Information This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, the Company's expectations with respect to the timing of the relisting of its common stock on a national securities exchange. These forward-looking statements are based on the current beliefs and expectations of the Company's management with respect to future events, only speak as of the date that they are made, and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "continue," "can," "may," "look forward," "aims," "hopes," and "seeks" and similar terms, although not all forward-looking statements contain such words or expressions. Actual results could differ significantly from those set forth in the forward-looking statements. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, among others: a further material delay in the Company's financial reporting or ability to hold an annual meeting of stockholders; an inability of the Company to timely prepare its delinquent financial statements; unanticipated factors or factors that the Company currently believes will not cause further delay; the Company's remediation efforts and preparation of financial statements or other factors that could cause additional delay or adjustments; the possibility that ongoing remediation work or the audit of the Company's financial statements for the fiscal year ended December 31, 2023 or the fiscal year ended December 31, 2024 may identify additional errors and material weaknesses or other deficiencies in the Company's accounting practices; the likelihood that the control deficiencies identified or that may be identified in the future will result in additional material weaknesses in the Company's internal control over financial reporting; risks relating to the Company's voluntary disclosure to the SEC of certain information relating to the investigation by the Audit Committee of the Company's Board of Directors, the SEC's investigation, and the additional information the Company has continued to provide to the SEC based on discussions with the SEC; changes in the financial condition of the markets that the Company serves; the Company's ability to hire qualified individuals to serve in senior leadership roles on a permanent basis, including a chief financial officer; and other factors contained in the "Risk Factors" section and elsewhere in the Company's filings with the SEC from time to time, including, but not limited to, the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The Company does not undertake to update any forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes over time, except as required by law. View source version on Contacts For more information contact: Investors:Jenny Media:Rick Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
a day ago
- Yahoo
University Hospitals launches RPM programme powered by HealthSnap
US-based University Hospitals (UH) has launched a remote patient monitoring (RPM) programme powered by HealthSnap to enhance care for patients with uncontrolled hypertension. Hypertension is stated to affect over 30% of adults in Ohio, contributing to thousands of avoidable hospitalisations. The programme aims to provide continuous support, improve health results, and minimise the need for hospital visits. UH operates a network of hospitals and outpatient facilities throughout northern Ohio. Once fully implemented at the UH Primary Care Institute, the RPM service will cover nearly 100 practice sites and support more than 400 providers. University Hospitals' chief medical officer Dr Anthony Muni said: 'At University Hospitals, we are committed to pushing the boundaries of what's possible in care delivery. 'Collaborating with HealthSnap enables us to better support patients with uncontrolled hypertension between visits, helping them stay connected, adherent, and on track toward healthier outcomes.' The programme enhances blood pressure management and facilitates timely clinical interventions by providing care teams with ongoing biometric and symptom data. HealthSnap's platform integrates seamlessly with UH's current workflows and EHR systems, ensuring a smooth experience for clinicians and patients alike. HealthSnap CEO Samson Magid said, 'University Hospitals is leading the way in redefining chronic care for the modern era. 'We are proud to support their bold vision with scalable RPM solutions that deliver meaningful outcomes without adding to provider burden.' Founded in 1866, UH serves communities across 16 counties in northern Ohio through a network of 21 hospitals, over 50 health centres and outpatient facilities, and more than 200 physician offices. The system is affiliated with several universities and maintains more than 3,000 active clinical trials. HealthSnap provides integrated RPM, chronic care management, and care coordination solutions for healthcare organisations across the US. "University Hospitals launches RPM programme powered by HealthSnap" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
